Best Radiation therapy for kidney cancer Doctors Worldwide — TOP 37

Dr. Solak specializes in radiation therapy for kidney cancer at Hisar Hospital Intercontinental, with training at Hacettepe University Cancer Institute.

• Completed fellowship at Hacettepe University Cancer Institute
• Worked at The University of Texas MD Anderson Cancer Center
• Experienced in treating various cancers including kidney cancer
• Graduated from Hacettepe University Faculty of Medicine

Prof. Atalar specializes in stereotactic radiosurgery for kidney cancer, with advanced training at Stanford University.

• Professor of Radiation Oncology at Acibadem MAA University
• Honorary Fellow of American College of Radiology (H.FACR)
• IASLC International Mentorship Award recipient
• 72 international peer-reviewed publications
• Expert in MR-Guided Adaptive SRS techniques

Specialized in soft tissue and bone sarcoma with decades of experience – Prof. Merimsky leads the Unit of Soft Tissue and Bone Oncology at Sourasky Medical Center.

• Fellowship-trained at Institut Gustave Roussy in Paris
• Member of ESMO Faculty for soft tissue and bone sarcoma
• Active in international oncology research and conferences
• Lecturer at Sackler Faculty of Medicine

Dr. Sarid specializes in kidney cancer radiation therapy at Sourasky Medical Center, with 38 years of experience as a senior oncologist and Oxford-trained expertise in cancer urology.

• Principal investigator for clinical trials in cancer therapies
• Published 30+ articles on cancer treatment
• Member of ESMO, ASCO, and Israeli oncology societies
• Lecturer at Tel Aviv University

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Doctor Sefik Igdem specializes in radiation oncology with advanced technologies like Truebeam Stx and Halcyons at Gayrettepe Florence Nightingale Hospital.

• 30 years of experience of experience in radiation oncology
• Expert in conformal treatments for precise targeting
• Associate professor at Demiroğlu Bilim University
• Special focus on prostate and head/neck cancers

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Ferentinos heads the Radiation Oncology Department at German Oncology Center, specializing in kidney cancer treatments.

• Over 13 years of experience of experience in radiation oncology
• Specialized in interventional radiation oncology techniques
• Holds a doctoral degree from Johann Wolfgang Goethe University
• Currently pursuing a Master’s in Healthcare Business Studies

Dr. Mehmet Dogu Canoglu specializes in advanced radiation therapies for kidney cancer at Anadolu Medical Center.

• Trained in radiation oncology at Kocaeli University
• Expert in MR Linac, CyberKnife, and Varian TrueBeam systems
• Experienced at major Turkish hospitals since 2012
• Currently serves at leading JCI-accredited Anadolu Medical Center

Dr. Dror Levin specializes in pediatric oncology, with a focus on bone cancer treatment at Sourasky Medical Center.

• Director of the children's hematology oncology department
• Coordinator for bone cancer and soft tissue sarcoma treatment
• Trained at Rizzoli Orthopaedic Institute in Italy
• Member of the Israeli Society of Pediatric Hemato-Oncology

Director of oncology hospitalization at Tel Aviv Medical Center – Dr. Stepfansky specializes in kidney cancer radiation therapy.

• Over 26 years of experience of experience in oncology
• Primary and secondary researcher in clinical oncology studies
• Trained at Tel Aviv Medical Center’s oncology program

Phd Viola Fox leads the Clinic for Haematology, Oncology and Palliative Care at BKZ Solingen – a certified interdisciplinary cancer center.

• Specialized in chemotherapy, immunotherapy, and radiation therapy
• Active in molecular biology research for haemato-oncological diseases
• Member of German Society of Oncology and Haemato-oncology
• Qualified specialist in genetics

Associate Professor Dr. Yusuf Acikgoz brings expertise from Ohio State University and active involvement in cutting-edge clinical trials for kidney cancer.

• Specializes in Medical Oncology with a focus on kidney cancer treatments
• Participated in Phase III CheckMate-649 and Fortitude-101 studies as Assistant Investigator
• Member of American Society of Clinical Oncology (ASCO) and Turkish Society of Medical Oncology
• Trained at prestigious institutions including Health Sciences University and Ankara Numune Training and Research Hospital

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Internal Medicine Specialist with experience at multiple oncology centers
• Promoted to Associate Professor in 2016
• Graduated from Selcuk University Faculty of Medicine

Specializes in medical oncology at Medical Park Antalya Hospital Complex, with training from Akdeniz University.

• Board-certified in internal medicine and medical oncology
• Extensive experience across university and training hospitals
• Focused on evidence-based oncology treatments
• Part of a dedicated oncology team

Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.

• Completed urological fellowships at Thomas Jefferson University and McMaster University.
• Expert in minimally invasive treatments for UTUC, kidney stones, and prostate cancer.
• Served as a researcher in the OLYMPUS trial for non-surgical chemoablation.
• Fellow of the American Endourology Society with over 60 scientific publications.